8.5 Nonprescription, Behind-the-Counter & Restricted OTC Products
Key Takeaways
- KRS 218A.1446(1) allows a pharmacist, pharmacy intern, OR pharmacy technician to sell ephedrine/pseudoephedrine products, while KRS 218A.190 reserves the exempt codeine sale to a pharmacist - the personnel rules differ by product.
- Kentucky caps ephedrine and pseudoephedrine purchases at 7.2 grams per 30 days; the 3.6 g daily ceiling comes from the federal Combat Methamphetamine Epidemic Act, and the state annual cap was repealed effective July 15, 2024.
- The pseudoephedrine log must be an Office of Drug Control Policy-approved electronic blocking system provided free to the pharmacy, initialed per sale, kept 2 years, and open to random warrantless law enforcement inspection.
- KRS 218A.1446(4) exposes both the individual (up to $1,000 per violation) and an employer that encourages incorrect entries through poor training or supervision, and supplies a defence for circumstances beyond the seller's control.
- An OTC drug dispensed against a prescription becomes a dispensed prescription: full KRS 217.816 label, patient profile entry, prospective DUR, and PPPA child-resistant packaging all apply.
8.5 Nonprescription, Behind-the-Counter & Restricted OTC Products
Competency Statement 3.8 is one of the largest single items on the MPJE blueprint, and it is routinely under-studied because candidates assume "OTC" means "unregulated." It has four sub-parts — dispensing or administration, labeling of non-prescription drugs and devices, packaging and repackaging of non-prescription and behind-the-counter products, and dispensing-restricted non-prescription drugs — and Kentucky has meaningful state-specific rules in each.
1. The Four Tiers of Non-Prescription Access
┌─────────────────────────────────────────────────────────────────────────────┐
│ NON-PRESCRIPTION ACCESS TIERS │
├─────────────────────────────────────────────────────────────────────────────┤
│ TIER 1 — OPEN SHELF OTC │
│ • Monograph or NDA-approved OTC drug; general sale; no pharmacist needed. │
│ • Governed by the FDCA OTC monograph system and the Drug Facts label rule.│
│ │
│ TIER 2 — BEHIND-THE-COUNTER BY STATUTE (methamphetamine precursors) │
│ • Ephedrine / pseudoephedrine / phenylpropanolamine — KRS 218A.1446. │
│ • Sale restricted to a pharmacist, pharmacy INTERN, or pharmacy │
│ TECHNICIAN; electronic blocking log; ID; age 18+. │
│ │
│ TIER 3 — EXEMPT CONTROLLED SUBSTANCE (pharmacist-only sale) │
│ • Exempt codeine preparations — KRS 218A.190 and 902 KAR 55:015 §6. │
│ • Sale restricted to a PHARMACIST; separate statutory registry; age 18+; │
│ not publicly displayed; <= 120 mL per person per 48 hours. │
│ │
│ TIER 4 — OTC PRODUCT DISPENSED AS A PRESCRIPTION │
│ • An OTC drug ordered on a prescription (often for insurance coverage) │
│ becomes a dispensed prescription: it needs a full prescription label, │
│ a patient profile entry, DUR, and child-resistant packaging. │
└─────────────────────────────────────────────────────────────────────────────┘
2. Ephedrine, Pseudoephedrine & Phenylpropanolamine (KRS 218A.1446)
This is Kentucky's most heavily litigated non-prescription statute, and its details are exam-favourites.
| Element | Requirement | Statutory Cite |
|---|---|---|
| Who may complete the sale | A registered pharmacist, a pharmacy intern, or a pharmacy technician | KRS 218A.1446(1) |
| Purchaser identification | Government-issued photo ID showing date of birth | KRS 218A.1446(2)(a) |
| Log contents | Date of transaction; purchaser name, date of birth, and address; amount and name of the preparation | KRS 218A.1446(2)(b) |
| Log medium | Only an electronic logging system approved by the Office of Drug Control Policy; the system must be provided to the pharmacy at no cost | KRS 218A.1446(2) |
| Initialing | The pharmacist, intern, or technician initials each sale entry | KRS 218A.1446(3) |
| Log retention | Two (2) years; subject to random and warrantless inspection by city, county, or state law enforcement | KRS 218A.1446(3) |
| 30-day quantity cap | 7.2 grams of base within any 30-day period (stricter than the federal 9 g) | KRS 218A.1446(5) |
| Annual cap | None — the former annual limit was repealed by 2024 Ky. Acts ch. 117, effective July 15, 2024 | KRS 218A.1446 |
| Age | Purchaser must be 18 or older; aiding a minor's purchase is separately prohibited | KRS 218A.1446(6) |
| Blocking mechanism | The approved system must block a sale that would exceed the quantity limits or that is prohibited under KRS 218A.1440 | KRS 218A.1446(10) |
| Form exemption | The section does not apply to liquid, liquid capsule, or gel capsule formulations | KRS 218A.1446(7) |
| Prescription exemption | The 30-day cap does not apply to quantities dispensed pursuant to a valid prescription | KRS 218A.1446(5) |
Penalties and the Employer Trap
KRS 218A.1446(4) creates two-sided liability. Intentional failure to make an accurate log entry, or failure to maintain the log, exposes the pharmacist, intern, or technician to a fine of up to $1,000 per violation and may be evidence of a violation of KRS 218A.1438. But if the employer fails, neglects, or encourages incorrect entry through improper training or lack of supervision, the employer also faces liability. The statute also supplies a defence for circumstances beyond the individual's control — fire, natural disaster, loss of power, robbery or shoplifting, a medical emergency on the premises, or a genuinely inadvertent omission.
Exam Trap — the daily limit is federal, not Kentucky. The 3.6 g/day ceiling comes from the federal Combat Methamphetamine Epidemic Act, and it applies in Kentucky because federal law applies in Kentucky. KRS 218A.1446 itself sets the 30-day 7.2 g cap and no daily figure. An item asking "under KRS 218A.1446, what is the limit?" is testing the 7.2 g / 30 days number.
Exam Trap — the technician may make this sale. Unlike the exempt codeine sale in Section 5.1, which the statute reserves to a pharmacist, KRS 218A.1446(1) expressly permits a pharmacist, intern, or technician to complete a pseudoephedrine sale. Candidates who apply one rule to both products get one of them wrong.
3. Labeling and Packaging of Non-Prescription Products
Labeling
- An OTC drug sold as an OTC drug carries the FDA Drug Facts panel (active ingredients, purpose, uses, warnings, directions, other information, inactive ingredients, questions/comments contact). No pharmacy label is added.
- An OTC drug dispensed on a prescription must carry a full Kentucky prescription label — the same elements required of any dispensed drug under KRS 217.816, including the patient's name, prescriber, directions, date, serial number, pharmacy name and address, and the dispensing pharmacist's identification. This is the single most common OTC-labeling item on the exam.
- A device sold OTC (blood-glucose meters, nebulizers, compression stockings) follows the FDCA device labeling requirements; when dispensed on a prescription it is labeled as a dispensed item.
Packaging and Repackaging
- PPPA child-resistant packaging applies to OTC products in the covered categories — the well-known examples are oral aspirin, acetaminophen, ibuprofen in the covered strengths, iron-containing products (250 mg or more of elemental iron per package), and oral nicotine replacement. The PPPA's exemption for a single non-CRC size applies only when the manufacturer also markets a compliant CRC size, and the request for a non-CRC container comes from the purchaser.
- Repackaging an OTC product for dispensing converts the pharmacy into the labeler for that container: the pharmacy must apply the required labeling, use suitable containers meeting USP standards, and maintain the record linking the repackaged unit to its source lot and expiration date.
- Beyond-use dating on repackaged solid oral dosage forms follows USP: the earlier of one year from the date of repackaging or the manufacturer's expiration date, unless stability data support otherwise.
4. Dispensing-Restricted Non-Prescription Drugs
| Product | Restriction | Source |
|---|---|---|
| Ephedrine / pseudoephedrine / PPA | Behind the counter; pharmacist, intern, or technician; ID; electronic blocking log; 7.2 g/30 days; age 18+ | KRS 218A.1446 |
| Exempt codeine preparations | Pharmacist only; registry; age 18+; not publicly displayed; <= 120 mL/48 hr | KRS 218A.190 |
| Naloxone / opioid antagonists | Available OTC federally; in Kentucky also dispensable by a pharmacist under a physician-approved protocol | 201 KAR 2:360; KRS 217.186 |
| Emergency contraception (levonorgestrel) | OTC without age restriction under FDA labeling | FDCA labeling |
| Dextromethorphan-containing products | Kentucky restricts sales to minors | KRS 218A.1447–.1449 |
| Nonprescription syringes | Sale permitted; pharmacist professional judgment governs | Kentucky harm-reduction policy |
Exam Trap — "OTC" never means "no records." Three of the six products above generate a mandatory transaction record that an inspector or a law enforcement officer can demand: the pseudoephedrine electronic log (2-year retention, warrantless inspection), the exempt codeine registry, and any protocol-dispensed naloxone record. An item asserting that a non-prescription sale creates no pharmacy record is testing exactly this.
A registered pharmacy technician at a Louisville pharmacy is asked to complete two behind-the-counter sales during the pharmacist's lunch relief: one box of pseudoephedrine 30 mg tablets and one 120 mL bottle of an exempt guaifenesin-with-codeine syrup. Both purchasers are adults with valid photo identification. What may the technician lawfully do?
Under KRS 218A.1446, which statement about Kentucky's ephedrine and pseudoephedrine sales requirements is correct?
A prescriber writes a prescription for ibuprofen 200 mg tablets, an over-the-counter product, so that the patient's insurance will cover it. Which statement correctly describes the Kentucky pharmacy's obligations when it dispenses this order?